Agencies › Department of Defense › NAICS 325414

Department of Defense (DoD): NAICS 325414 — Biological Product (Except Diagnostic) Manufacturing

3open solicitations

$83.9Mobligated in FY2026

2contracts ending within 18 months

Open solicitations

Injectable Egg-Free Influenza Vaccine 2027DLA · Unrestricted (full and open) · Due 08 October 2026
Injectable Influenza Vaccine 2027DLA · Unrestricted (full and open) · Due 08 October 2026
2027 Southern Hemisphere Influenza VaccineDLA · Unrestricted (full and open) · Due 14 October 2026

How DoD NAICS 325414 spends

FY2021$2.7B

FY2022$27.2M

FY2023$47.8M

FY2024$67.4M

FY2025$31.3M

FY2026$83.9M

Contract obligations by federal fiscal year (October–September), from USASpending.gov award data. IDIQ ceilings are excluded. * The current year is partial, and USASpending lags 4–8 weeks.

DoD NAICS 325414 contracts expiring in the next 18 months

2 contracts worth $36.5M.

Incumbent	Buyer	What	Value	Ends	Est. solicitation	Record
MERIDIAN MEDICAL TECHNOLOGIES, LLC	DLA	325414 Biological Product (Except Diagnostic) Manufacturing	$36.5M	26 February 2027	Now / imminent	USASpending
LAMPIRE BIOLOGICAL LABS INC	Defense Health Agency	325414 Biological Product (Except Diagnostic) Manufacturing	$70K	31 March 2027	Now / imminent	USASpending

Contracts and task orders from USASpending.gov (FPDS) whose period of performance ends within 18 months, valued at $25K or more, excluding IDIQ ceilings and government-owned, contractor-operated facility contracts. Co-terminous orders from the same vendor, agency, NAICS and PSC ending in the same month are grouped. The solicitation date is an estimate (about six months before the contract ends): FedSift does not know whether a follow-on has been posted, so check SAM.gov.

NAICS 325414 across every agency → · Everything DoD has open →